Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Cingal Study for Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Cingal Study for Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01891396).
- Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03850379).
- Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine: Complete Statistical AnalysisIndependent statistical analysis of Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01402947).
- Circadian Brown Adipose Tissue Metabolism: Complete Statistical AnalysisIndependent statistical analysis of Circadian Brown Adipose Tissue Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02285270).
- Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CIRTIndependent statistical analysis of Cardiovascular Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01594333).
- CIRTIndependent statistical analysis of Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02576067).
- CIS2Independent statistical analysis of Safety and Efficacy of Chronic Hypnotic Use 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02456532).
- Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Citicoline in Non-Arteritic Ischemic Optic Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Citicoline in Non-Arteritic Ischemic Optic Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03758118).
- Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01026623).
- Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CLANIndependent statistical analysis of Contact Lens Adaptation in Neophytes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02148263).
- CLARAIndependent statistical analysis of A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clareon PanOptix Pro vs. Clareon PanOptix – Study A: Complete Statistical AnalysisIndependent statistical analysis of Clareon PanOptix Pro vs. Clareon PanOptix - Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06400745).
- Clareon Toric vs Eyhance Toric: Complete Statistical AnalysisIndependent statistical analysis of Clareon Toric vs Eyhance Toric: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05481125).
- Clarion-CKDIndependent statistical analysis of Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00840411).
- Clarithromycin Mechanisms in Hypersomnia Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Clarithromycin Mechanisms in Hypersomnia Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04026958).
- CLARITYIndependent statistical analysis of A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CLARITY-1Independent statistical analysis of Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant: Complete Statistical AnalysisIndependent statistical analysis of Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03380962).
- CLBP Single-Arm Long-Term Follow-up Study: Complete Statistical AnalysisIndependent statistical analysis of CLBP Single-Arm Long-Term Follow-up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05207813).
- CLEARIndependent statistical analysis of Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CLEARIndependent statistical analysis of Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02937350).
- CLEAR 2Independent statistical analysis of Combining Lesinurad With Allopurinol in Inadequate Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493531).
- CLEARANCEIndependent statistical analysis of CLinical Evaluation of Aspiration for Removal ANd ClearancE of Stones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06615713).
- CLEOPATRAIndependent statistical analysis of CLEOPATRA, the randomized phase 3 trial of pertuzumab plus trastuzumab and docetaxel versus placebo plus trastuzumab and docetaxel in previously untreated HER2-positive metastatic breast cancer.
- CLEVERIndependent statistical analysis of Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04767373).
- CliffhangerIndependent statistical analysis of A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CLIN-011Independent statistical analysis of A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CLIN01Independent statistical analysis of Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis: Complete Statistical AnalysisIndependent statistical analysis of Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage: Complete Statistical AnalysisIndependent statistical analysis of Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals: Complete Statistical AnalysisIndependent statistical analysis of Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Clinical Assessment of a HYDRAGLYDE® Regimen: Complete Statistical AnalysisIndependent statistical analysis of Clinical Assessment of a HYDRAGLYDE® Regimen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03026257).
- Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Clinical Assessment of a Novel Microprobe Array Continuous Glucose Monitor for Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Clinical Comparison of the Airway Devices: Complete Statistical AnalysisIndependent statistical analysis of Clinical Comparison of the Airway Devices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00581386).
- Clinical Comparison of Two Daily Disposable Contact Lenses in a Population of Daily Disposable Contact Lens Wearers: Complete Statistical AnalysisIndependent statistical analysis of Clinical Comparison of Two Daily Disposable Contact Lenses in a Population of Daily Disposable Contact Lens Wearers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Clinical Comparison of Two Silicone-Hydrogel Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Clinical Comparison of Two Silicone-Hydrogel Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00762385).
- Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain: Complete Statistical AnalysisIndependent statistical analysis of Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain: primary endpoint results, effect estimate with confidence…
- Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity: Complete Statistical AnalysisIndependent statistical analysis of Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension: Complete Statistical AnalysisIndependent statistical analysis of Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01515865).